HUSSMAN STRATEGIC ADVISORS, INC. - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2014$9,033,000
-1.5%
1,087,0000.0%0.68%
+3.7%
Q4 2013$9,174,000
-48.1%
1,087,000
-51.0%
0.65%
-32.7%
Q3 2013$17,677,000
-18.5%
2,218,000
-21.0%
0.97%
-1.6%
Q2 2013$21,685,000–2,809,000–0.99%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2013
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders